Table 5.

Patient Characteristics

	PCA Group (n = 35)	Non-PCA Group (n = 16)
Age (years, mean, range)	11.1 (0.8–20)	12.5 (0.8–21.5)
Gender (males)	54% (19/35)	56% (9/16)
Weight (kg, mean, SD)	44 (27)	51 (29)
Diagnosis
Solid tumor	37% (13/35)	44% (7/16)
Hematologic	49% (17/35)	19% (3/16)
Nonmalignant	14% (5/35)	38% (6/16)
Type of BMT
Myeloablative	91% (32/35)	31% (5/16)
Nonmyeloablative	9% (3/35)	69% (11/16)
Prep regimen, including TBI	17% (6/35)	19% (3/16)

BMT = bone marrow transplant; PCA = patient-controlled anesthesia; TBI = total body irradiation.